Adrian Covic @accovic

Professor Internal Medicine and Nephrology, MD, PhD, FRCP (London), FERA Try tweets for the fun of science, go to Journals for the fun science Joined October 2012

Tweets

2K
Followers

1K
Following

879
Likes

3K

AJKD @AJKDonline

4 days ago

Review on therapies for proliferative and membranous lupus nephritis with a focus on strategies targeting underlying mechanisms of disease in LN: “A Change Is Gonna Come” to Treatment of Lupus Nephritis bit.ly/43X14f5 (FREE) @TWhittier_RUSH @Rush_Nephrology

0 33 59 4K 34

View Details

Zara Quinn @_Zaraquin

5 days ago

Spanish goalkeeper in the world cup finals 😂😂

1K 22K 120K 3.1M 9K

View Details

Jonathan Chávez @JonathanNefro

a week ago

Con diabetes que ya consumen iSRAA y iSGLT2, agregar calcio antagonistas (ej amlodipino), comparado a otro antihipertensivo; se asoció a ↑33% el riesgo del evento renal mayor Hipótesis: dilatación arteria aferente e ↑hiperfiltración Kidney Med 2026 10.1016/j.xkme.2026.101394

6 48 164 7K 66

View Details

ClarksonsFarm @ClarksonsFarm1

a week ago

58 385 5K 54K 21

View Details

Adrian Covic @accovic

2 weeks ago

New data and paper from our group

0 1 4 316 0

View Details

Anish Koka, MD @anish_koka

4 weeks ago

The full story — the emails, the two database locks, the securities litigation machinery that accidentally became a public health accountability mechanism, the revolving door, and what it means for rare disease drug approvals — is at the link. open.substack.com/pub/anishkokam…

8 20 131 11K 37

View Details

Benny Johnson @bennyjohnson

3 weeks ago

Robin Williams’ emotional tribute to the American Flag leaves an entire stadium speechless — then in tears. Is there a single Hollywood star who would give this performance today? Total Patriot. RIP Legend 🇺🇸

1K 19K 74K 1.3M 15K

View Details

Adrian Covic @accovic

a month ago

agerpres.ro/comunicate/202…

2 0 2 125 0

View Details

Jonathan Chávez @JonathanNefro

a month ago

En incidentes en hemodiálisis, el 22% desarrolló síndrome de desequilibrio postdialítico realizando un protocolo de dosis incremental por sesión. Sorprende que ni el síndrome urémico, ni la urea fueron factores asociados a esta complicación CKJ 2026 academic.oup.com/ckj/advance-ar…

1 25 73 3K 16

View Details

CKJ @CKJsocial

a month ago

Measuring effectiveness in immunoglobulin A nephropathy: what are we looking for? doi.org/10.1093/ckj/sf…

0 18 32 2K 15

View Details

ClarksonsFarm @ClarksonsFarm1

a month ago

The best news!🤩

623 1K 22K 480K 222

View Details

Circulation @CircAHA

2 months ago

2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome ahajrnls.org/4onYYOk

1 26 49 4K 10

View Details

AHA Science @AHAScience

2 months ago

Published today, the first-ever clinical practice guideline on cardiovascular-kidney-metabolic (CKM) syndrome from the American Heart Association and @ACCinTouch. The focus of this clinical practice guideline is to create a living, working document that provides current knowledge in the field of CKM syndrome aimed at all practicing cardiologists, endocrinologists, nephrologists, and primary care and specialty clinicians who manage these patients. ✍🏼 @ChiadiNdumele @HeartDocSadiya @kardiologykazi @noshreza @virani_md @biykemb @NutritionHF @mandeepbajaj65 @KatherineTuttl8 @RangaswJ @lisaVWMD @KBreathettMD @EmoryFamMed @ShoaClarke @mad_sters @jmortonmd @sripalbangalore @AnumSaeedMD

6 260 513 68K 222

View Details

Adrian Covic @accovic

2 months ago

A new paper from our group

0 2 6 755 0

View Details

NEJM @NEJM

2 months ago

Original Article: Obexelimab for the Treatment of IgG4-Related Disease (phase 3 INDIGO trial results) nej.md/4fKYQG4 Editorial: Obexelimab and the Promise of Nondepleting B-Cell Therapy in IgG4-Related Disease nej.md/4fLybcd #EULAR2026 | @eular_org

2 37 104 19K 22

View Details

Brendon Neuen @brendonneuen

2 months ago

Join us tomorrow at @ERAkidney for the launch of the CLARITY-IgAN Consortium in the high impact clinical trials in nephrology session (starting at 8:15 BST) A collaborative meta-analysis of the efficacy and safety of B-cell therapies in IgAN clarity-igan.org #ERA26

0 10 30 1K 3

View Details

Bret Scher, MD @bschermd

2 months ago

Cardiology calls statins miracle drugs. Social media calls them poison. Both sides cite published scientific papers. How can they be looking at the same evidence and reaching opposite conclusions? As a cardiologist, I think both sides are are on to something. Let me explain. 🧵

78 136 904 358K 2K

View Details

ClarksonsFarm @ClarksonsFarm1

2 months ago

20 597 3K 33K 50

View Details

Scott Isaacs @scottisaacsmd

2 months ago

SURPASS‑EARLY evaluated starting tirzepatide early in type 2 diabetes vs. conventional step-therapy. In adults with early T2D on metformin, tirzepatide produced larger 2‑year reductions in HbA1c, weight, and waist circumference than intensified conventional care, and more participants achieved normoglycemia. Although the open‑label design can introduce reporting bias and patients with very high baseline HbA1c (>9.5%) were excluded, the findings support considering GLP medications earlier to establish better and potentially more durable glycemic control than stepwise conventional care. acpjournals.org/doi/10.7326/AN…

0 19 63 5K 22

View Details

Crémieux @cremieuxrecueil

2 months ago

This is pretty awesome. Basically, they're creating a whole journal that's dedicated to post-publication peer review: criticizing papers after they're published in another venue. A lot of papers need this because so many are horrendously bad. I hope this succeeds!

Colin Wright @SwipeWright

2 months ago

ANNOUNCEMENT: WE’RE SAVING SCIENCE! We’re often told that science is “self-correcting.” But that’s not really true. Science doesn’t correct itself like a thermostat adjusting the temperature in your house. Science is a human institution run by human beings. And human beings